IRF7 and COVID-19: In a recent epigenome-wide association study (EWAS), the authors detected the methylation statuses of CpG sites in IRF7 via the methylation EPIC array in the peripheral blood samples of COVID-19 patients and found the different methylation statuses of CpG sites to be significantly associated with different disease severities [110].